Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers.

MLA

Potter, Rachel, et al. “Increased in Vivo Amyloid-Β42 Production, Exchange, and Loss in Presenilin Mutation Carriers.” Science Translational Medicine, vol. 5, no. 189, June 2013, p. 189ra77. EBSCOhost, https://doi.org/10.1126/scitranslmed.3005615.

APA

Potter, R., Patterson, B. W., Elbert, D. L., Ovod, V., Kasten, T., Sigurdson, W., Mawuenyega, K., Blazey, T., Goate, A., Chott, R., Yarasheski, K. E., Holtzman, D. M., Morris, J. C., Benzinger, T. L. S., & Bateman, R. J. (2013). Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers. Science Translational Medicine, 5(189), 189ra77. https://doi.org/10.1126/scitranslmed.3005615

Chicago

Potter, Rachel, Bruce W Patterson, Donald L Elbert, Vitaliy Ovod, Tom Kasten, Wendy Sigurdson, Kwasi Mawuenyega, et al. 2013. “Increased in Vivo Amyloid-Β42 Production, Exchange, and Loss in Presenilin Mutation Carriers.” Science Translational Medicine 5 (189): 189ra77. doi:10.1126/scitranslmed.3005615.